Seletracetam

Seletracetam

File:Seletracetam.svg
File:Seletracetam3d.png
Clinical data
Routes of administration	Oral
Legal status
Legal status	Unscheduled (US)
Pharmacokinetic data
Bioavailability	>90%
Elimination half-life	8h
Identifiers
IUPAC name (2S)-2-[(4R)-4-(2,2-difluoroethenyl) -2-oxo-pyrrolidin-1-yl]butanamide
PubChem CID	9942725
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C10H14F2N2O
Molar mass	232.227
3D model (JSmol)	Interactive image
SMILES CCC(C(=O)N)N1CC(CC1=O)C=C(F)F

Seletracetam is a drug of the racetam family. It is currently being developed by UCB Pharmaceuticals as an anticonvulsant drug. While similar in structure to so-called nootropic drugs, it is not expected to have cognitive enhancing properties.

See also

• Racetams